The United States has begun rerouting travellers who have passed through the Democratic Republic of Congo, Uganda, or South Sudan in the previous twenty-one days to three designated airports: Washington Dulles, Atlanta Hartsfield-Jackson, and Houston Bush Intercontinental. NPR reports that non-citizens and non-permanent residents are largely barred from entry under a CDC Title 42 order; green card holders will be considered case by case. The outbreak, which the WHO declared a Public Health Emergency of International Concern on May 17, involves a rare Ebola strain for which no vaccine exists. The Guardian’s reporting indicates roughly 800 suspected cases and more than 180 suspected deaths. Health facilities in the affected regions are at capacity. Red Cross volunteers have died from suspected Ebola in the DRC, and the White House has paused deportations to the country as the situation deteriorates.
The received wisdom
The public health establishment’s reaction to US travel restrictions on Ebola-affected countries has been consistent across multiple outbreaks: travel bans and entry restrictions are theatrically reassuring and epidemiologically counterproductive. They drive affected travellers to hide their itineraries, divert them through third countries with less screening capacity, and create economic pressure on the affected nations that complicates cooperation. Former CDC official Dr. Marty Cetron has stated plainly that travel bans “rarely work in and of themselves” and that resources must be surged to the source country. The comparison to 2014–2016 is instructive: during that outbreak, the US deployed over 3,000 military, CDC, and USAID personnel to West Africa, maintained open travel with active monitoring, and eventually contained the virus. The current US response has deployed “several dozen” CDC staff. USAID, which provided the logistical backbone for source-country containment, was abruptly shuttered in 2025.
A different read
The experts are right on the epidemiology, and wrong to use it as an excuse to avoid discussing the governance failure that produced the current situation.
The 2014 comparison is illuminating precisely because of what has changed. The Obama administration’s response to Ebola was not popular at the time — there was significant political pressure, including from several Republican governors, to close borders entirely — but it was executed by an intact public health apparatus. CDC had a full complement of field epidemiologists. USAID had functioning country offices in the DRC and neighbouring states. The State Department had senior officials fluent in regional politics and health diplomacy. These were not luxury capacities; they were the operational infrastructure that allowed the US to do the harder, more effective work of containment at source rather than the easier, less effective work of keeping sick people out at the airport.
What NPR’s reporter Michal Ruprecht found at Dulles is worth dwelling on. The CDC clinic was a makeshift tarp structure. Screening consisted of a temperature check and a questionnaire. No thermometer, no burner phone, no printed instructions were distributed — unlike 2014 protocol. Ruprecht received a text message the following day listing Ebola symptoms. Virginia’s state epidemiologist, Dr. Laurie Forlano, described the initial chaos as “part of the gig.” Her state was simultaneously managing a measles outbreak and hantavirus monitoring. Dr. Jeanne Marrazzo, former NIH official and CEO of the Infectious Diseases Society of America, described plainly the “decimation of local, regional and state public health staffing” over the past five years.
This is a conservative policy failure, not a liberal one, and it ought to be acknowledged clearly. The dismantling of USAID, the reduction in CDC field capacity, the attrition of state public health departments — these were choices, not accidents. They reflected a governing philosophy that regards multilateral health infrastructure as a form of globalist overreach and prefers visible border control to invisible preparedness. Border control is not illegitimate; the rerouting order is not inherently wrong. But it is a second-rate substitute for the first-rate response that would have surged resources to Kinshasa when the outbreak was fifty cases rather than eight hundred.
There is also the specific detail that this Ebola strain has no available vaccine. The vaccines used effectively in the 2018–2020 DRC outbreak were developed through a research infrastructure that includes partnerships between NIH, USAID-funded international labs, and DRC health authorities. The quality of that research infrastructure today is directly related to what was preserved and what was cut. Preparing for the next outbreak requires investment in the outbreak you are currently watching. The tarp clinic at Dulles is not the story; it is the symbol.
What to watch
Track whether the outbreak breaks out of DRC and Uganda into neighbouring countries — particularly Rwanda, Burundi, or Tanzania — which would escalate the response complexity and the pressure on US entry points. Watch the WHO’s declared emergency status: a sustained PHEIC triggers international funding mechanisms and voluntary travel advisories that may produce the coordinated response that US unilateral restrictions cannot. Look for any movement on rebuilding USAID’s country office capacity, even on an emergency basis; an administration that has just paused deportations to DRC is making a functional acknowledgement that the country’s situation matters. The harder question is whether that acknowledgement translates into resources at the source. And follow the vaccine research pipeline: if a candidate for this strain exists in NIH’s portfolio, watch whether funding has been maintained or cut in the broader public health budget reductions.
— J